Teva Israel is moving forth. Taiwan's study results have to be submitted to the regulatory authority but we should see approval there. Eisai is responsible for Switzerland, EU, Canada, Mexico and Brazil. You should direct your comments to the right company and as either an investor or basher, you should know more about what you write about but lying is like your leaky diaper, you like sheeting all over the place. Then you will like Tecumsheet, he is the man for you, a psycho who like leaky diapers...
There are no heart valve problems and no brain issues. The placebo arm had the same number of valvulopathy issues as the drug arms. There is a 25X safety margin regarding malignant breast tumors. Actually higher than that since only the 82X arm had a slightly higher number of malignant tumors versus the placebo arm.
In fact that the lower dosages of 7X and 24X, the placebo arms had slightly more malignant tumors in the pre-clinical studies. There were no stat significant tumors of any type found in the clinical studies.
50% or more of responders have lost 25 pounds to 90 pounds on belviq. Not a few pounds by an stretch of the imagination. Belviq works, your bashing and lying doesn't work. You better watch out or I'll have my man Tecumsheet take care of you.
Arena did not take in $9M on B, that is an outright freakin lie! Read the transcript Goofy, that is if you can read beyond the kindergarten level. Tell me when one of the patents has produced one cent of revenue? Come on now, the answer is never!
More lies from a Cretin momojobaloney - that means you moron - they did not get $250M up front. Are you related to Josef Goebbels?
Next lie, Arena raised money at high stock prices. And the lies from your lying sheet filled mouth and hands continue, Arena cannot announce EU tomorrow because Eisai is not ready to refile, but since you are a liar, moron and just plain momojobaloney you don't even know that Eisai is now responsible for the refiling but yet another meeting needs to take place and then labs needs to be done and even after refiling, the whole 210 day (non-linear) process takes place. EU is at least 3 freaking years away from one bottle of B being sold there.
Your last piece of BS is that Arena has cash for two years, not at the current burn rate and the BS amount of revenue coming into Arena. Now half of that $9M was from other sources other than straight up sales of B.
Milestone payments (money already spent so it doesn't add to cash) accounted for as part of that revenue.
Maybe the Roivant upfront payment which would add to cash, but I don't want to tax your miniature brain since it already exploding with the sheet that is in it.
Now get lost you #$%$ punk!!!
Basically B's number are ___________________just like Jack's holding a CC
In next CC, Jack won't be saying 8.6% growth over the prior quarter. The question people here should be really asking day in and day out is what if PFE or MRK or GSK were the partner, where would the scripts be? Very much higher is the answer.
How about you taking a math class. They are only covering 1/4 of their expenses and it might make 1/3 by EOY. There is no Compound 21 except in your imagination. You never ever been inside a Arena Bldg. I have and know more about Arena in my pinky finger than you will ever know. As long as Eisai's is involved, there will be no improvement in Belviq's fortunes at all.
They are reducing their spend after hearing from many concerned investors about reduction of infrastructure. The needed cuts are coming. The good news is that this will allow them to focus on 334 first and foremost.
Eisai has no stomach for moving any other B indications along and this has been clear for a few months. All you need to do SV is read the Eisai blog on CafePharma. Yes, you have to filter some of the BS, but so far most of the soothsayers on their have been correct and they will be correct with the continuing cutbacks that Eisai is planning.
Taiwan has to complete the study being done and then file, meaning approval in Taiwan is at least 12-15 months away. Teva is much closer. But unfortunately, neither Israel or SK are going to make up for the huge shortfall by the inept Eisai sales and marketing team that are leaving by the droves as I write.
Jack is under severe pressure with Tina Nova pointy toe high heel shoe up his scrotum.
As we heard on the CC, his brain farts are getting worse.
Regarding Wellington Fund, their Arena holdings amount to a pimple on an Elephant's #$%$ compared to the majority of their stock holdings.
This is the real weekend report of reality and not fantasy tales. You should try out for playing Pinocchio in Disney World or Disneyland, whichever one is closest to the mental institution that reside in, since you have all the attributes like the ability of your nose to grow longer from the more than wild tales you write on message boards.
Just remember SV, your my milkshake….
They have made a lot of dough on shorting Arena this few weeks….LOL
Nice find my rear end. Any moron using a search engine could find this…..
They have 300+ people and a good number of those jobs are not research jobs. Belviq XR is already developed. Come back when you know what you are talking about.
We don't know that at all Sharon. It has the potential to be very effective but let's not get ahead of ourselves with unproven comments. Has it been in a head to head study with RCPT's drug. No is the answer.
As I said to another poster on IVB in a personal message, would he be willing to go into a meeting with 5 top scientists from RCPT and 5 from CELG to really dig into the how they would really stack up against each other. If CELG thought that ADP334 is going to be that much better, they would have bought Arena not RCPT. I know RCPT is further ahead but not that much further ahead in the pharma World.
There is a long way to go before any lay person should make these types of statements.
Not really, treating addiction with belviq, other than possibly SC is down on the priority list at this time by Arena and their more than hapless partner called Eisai.
Dr. Lopez, by any stretch of the imagination is not a pumper. He posted useful information about what else is going on with Belviq, since the more than inept Eisai doesn't have the capability or the competence to PR this type of information.
His involvement is simple, he owns shares in Arena. He does not to the best of my knowledge, prescribe belviq to his patients since he is a OB/GYN Doctor. He also has the smarts if he did prescribe Belviq to patients to not discuss their outcomes on a public message board unlike the RMRMD (sp) dude that must have got a updated education on the more stringent Hippa requirements on PHI.
As Sharon states below, get a life.
Dr. Lopez is an ex-Veteran of the USMC and as such, unless you served your Country, you have no right questioning him in this fashion.
BS, and the person that died was taking several other medications with more serious side effects than B.
The disabled person's disability was not determined to be caused by Belviq.
Just like some longs stretch the truth, you as a dumb sheet basher have outdone yourself in getting the facts correct. Just a cockroach that Phillydan will stomp on like the slimy roach that you are.
Safety endpoints will include physical examination, electrocardiogram, adverse events (AEs), standard laboratory tests, and mental health assessed by the Columbia Suicidality Severity Rating Scale (C-SSRS) and Patient Health Questionnaire (PHQ-9).
Statistical Analysis. The planned sample size of 136 participants, with a 1:1 randomization ratio, assumes a 20% drop-out rate (at month 12) and was estimated to be adequate to evaluate the primary endpoint with power ≥90% (P=0.05, two-sided test). The investigators predict a difference in weight change between the two groups (from randomization to month 12) of 4 kg (SD=3.5). Pre-specified data analysis will be performed on the full analysis set, comprising all randomized individuals exposed to trial drug with at least one post-randomization weight assessment.
Estimated Enrollment: 136
Study Start Date: January 2015
Estimated Study Completion Date: April 2018
Estimated Primary Completion Date: April 2018 (Final data collection date for primary outcome measure)
Study is still recruiting for those that live in the Phila. PA area.
More information can be found on the Clinical Govs website by typing in Eisai in the search field. It is trial record 232.
How about this much more important study in collaboration with the University of Penna. Your study only has 24 patients to make sure of the safety of B-XR.
Same place you did your DD.
The proposed 12-month randomized controlled trial will assess the efficacy of lifestyle counseling, combined with lorcaserin (10 mg BID) or placebo, in maintaining weight loss achieved during a prior 14-week dietary run-in.
14-week run-in. To qualify for randomization, participants must lose ≥7% of initial weight in the 14-week dietary run-in. This loss will be achieved with the provision of weekly, group lifestyle counseling, which includes a 1000-1200 kcal/day portion-controlled diet that combines four daily servings of a liquid diet (HMR shakes) with an evening meal of a frozen-food entree (and a fruit and vegetable serving). More than 85% of participants are expected to achieve the 7% criterion loss during the 14-week run-in.
A total of 160 women and men with a BMI ≥33 and ≤55 kg/m2, without co-morbidities, or ≥30 and ≤55 kg/m2 (with a co-morbid cardiovascular disease (CVD) condition) will be enrolled in the 4-month run-in period. Prior to enrollment, all participants will have a history, physical exam, electrocardiogram (EKG), and appropriate blood tests. They will attend weekly group sessions for 14 weeks. Participants will have a brief medical visit at week 8 to check their health and blood tests will be repeated. The investigators anticipate that 136 (85%) participants will lose 7% or more of initial weight and qualify for randomization. Participants who do not lose 7% will be provided a list of weight loss resources (e.g., other programs) to facilitate their continued weight management.
To be continued:
Steady declining income you forgot to add. Full pipeline that will produce an approved drug in 4-6 years. Do the math on how long each drug will take if they make it to approval. The income doesn't even get close to offsetting the cash burn. Anyone recommending this load of #$%$ needs a education in math and how to read the data from their CC's. Burn rate is $35M/quarter, the net difference is about $30M going out the door and reducing the cash balance. Get the facts straight.
Actually HR, they are more informative than most of the information that gets posted here. Aside from the fact that like me he thinks it is time for Jack to go, all of his other information about Arena is positive. There are certain posters here that think that if you don't like Jack, you don't like Arena and the pipeline. That is rubbish thinking. Arena is defined by all of the good people that work there and the good drug development work they do there. The problem is Jack gets say too much credit when in fact, it is the players (Dominick and Shanahan hired not Jack) that deserve the credit. Jack's main job is to drive the stock price up using all of the good stuff happening at Arena and to fix the Eisai partnership. So far, he has not been able to accomplish that, when a certain few persons finally have that sink into their skulls and they stop the BS crybaby talk - I guess their childlike minds can't do better.
Yes, there is a story. But if you want to hear it, then you need to send me an email. It is not something that I would post on this board or IVB. Regarding U of Chicago, it sounds like that Cindy may no longer be in her position assuming she is attending U of Chicago in person as opposed to over the Internet, which is possible or may U of Chicago has an extension program in Switzerland.
Let me be clear Bronzeboy and you are a boy. If you were a man or a person that had any backbone, you would have contacted by email to get my phone number so we can have voice to voice conversation and see if you will repeat the comments to me that you so freely write on a message board because the simple fact is you are terrified of me. So continue to write your stupid posts, but it won't change the fact that you are just a spineless coward hiding behind a message board.